Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,611 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00502502 | Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients | completed | — | 205 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT00073866 | Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00005868 | Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer | completed | Phase 2 | 47 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 18, 2012 | clinicaltrials |
| NCT00006352 | Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer | completed | Phase 3 | 453 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00065429 | Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 64 | ImmunoGen, Inc.INDUSTRY | 1 | Jul 18, 2012 | clinicaltrials |
| NCT01141946 | Pleural Ultrasonography in Lung Cancer(CT0018) | completed | — | 46 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Jul 17, 2012 | clinicaltrials |
| NCT00103051 | Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 16, 2012 | clinicaltrials |
| NCT00050960 | Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | completed | Phase 3 | 612 | Eisai Inc.INDUSTRY | 6 | Jul 13, 2012 | clinicaltrials |
| NCT00238602 | Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer | completed | Phase 1 / Phase 2 | 48 | Stanford UniversityOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT00401492 | MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 159 | National Cancer Institute, NaplesOTHER | 0 | Jul 13, 2012 | clinicaltrials |
| NCT00529984 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies(CEA(6D)VRP) | completed | Phase 1 / Phase 2 | 28 | AlphaVax, Inc.INDUSTRY | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00003989 | ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma | completed | Phase 2 | 50 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT01636973 | Effects of Humidified Ventilation on Arterial Oxygenation and Respiratory Mechanics During One Lung Ventilation | completed | N/A | 60 | Yonsei UniversityOTHER | 1 | Jul 10, 2012 | clinicaltrials |
| NCT00002623 | Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | completed | Phase 3 | 640 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 2, 2012 | clinicaltrials |
| NCT00002972 | Paclitaxel in Treating Patients With Lung Cancer | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 2, 2012 | clinicaltrials |
| NCT00003062 | Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | 70 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 2, 2012 | clinicaltrials |
| NCT00890903 | Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC) | completed | — | 62 | Pierre Fabre Pharma GmbHINDUSTRY | 1 | Jul 2, 2012 | clinicaltrials |
| NCT01023828 | K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications(007/055/OMI) | completed | — | 150 | National Institute of CancerologíaOTHER_GOV | 1 | Jun 29, 2012 | clinicaltrials |
| NCT00826878 | An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 17 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00094094 | Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 32 | PfizerINDUSTRY | 2 | Jun 26, 2012 | clinicaltrials |
| NCT01378598 | Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer | completed | N/A | 30 | Dana-Farber Cancer InstituteOTHER | 0 | Jun 26, 2012 | clinicaltrials |
| NCT01152463 | Sonography After Thoracic Surgery (SATS) | completed | — | 120 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Jun 22, 2012 | clinicaltrials |
| NCT01011595 | Minimally Invasive, Diagnosis and Staging of Lung Cancer | completed | N/A | 166 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Jun 21, 2012 | clinicaltrials |
| NCT00887549 | A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 2 | Jun 19, 2012 | clinicaltrials |
| NCT00367679 | Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer | completed | Phase 2 | 35 | GlaxoSmithKlineINDUSTRY | 3 | Jun 12, 2012 | clinicaltrials |
| NCT00006457 | Oltipraz in the Prevention of Lung Cancer in People Who Smoke | completed | Phase 1 | — | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00058006 | Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00312975 | Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 90 | AstraZenecaINDUSTRY | 5 | Jun 7, 2012 | clinicaltrials |
| NCT00004096 | Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00478049 | Iressa as Second Line Therapy in Advanced NSCLC-Asia(ISTANA) | completed | Phase 3 | 163 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00745875 | ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study | completed | Phase 2 | 66 | AstraZenecaINDUSTRY | 5 | Jun 6, 2012 | clinicaltrials |
| NCT00217698 | Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 63 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00238251 | Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases | completed | Phase 2 | 59 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00088556 | Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 100 | TelikINDUSTRY | 1 | May 31, 2012 | clinicaltrials |
| NCT00330746 | CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer(CALC-1) | completed | Phase 2 | 100 | National Cancer Institute, NaplesOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00061854 | Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00251446 | A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00251524 | A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC | completed | Phase 2 | 69 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00098254 | BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00497770 | An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed | completed | — | 434 | Eli Lilly and CompanyINDUSTRY | 2 | May 2, 2012 | clinicaltrials |
| NCT00268970 | Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Apr 30, 2012 | clinicaltrials |
| NCT00807066 | Randomized Gefitinib Trial(RANGE) | completed | Phase 3 | 1 | Fondazione Humanitas per la RicercaOTHER | 1 | Apr 23, 2012 | clinicaltrials |
| NCT01581346 | Exercise Study in Patients With Lung Cancer(POSITIVE) | completed | Phase 2 | 40 | German Cancer Research CenterOTHER | 1 | Apr 20, 2012 | clinicaltrials |
| NCT00652340 | APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer(TP2001-201) | completed | Phase 2 | 120 | Tragara Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 9, 2012 | clinicaltrials |
| NCT00698516 | Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer | completed | Phase 2 | 50 | GlaxoSmithKlineINDUSTRY | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00692640 | Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors | completed | Phase 1 | 35 | SanofiINDUSTRY | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00442754 | Dendritic Cells in Lung Cancer | completed | Phase 2 | 50 | Herlev HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jul 20, 2012source: clinicaltrials